Structured evidence table for Niacinamide Skin Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Niacinamide Skin Randomized Trial | After 112-day use of REGENMEDIC cream and serum, test group showed increased skin elasticity and firmness, reduced wrinkles, and an overall improvement in skin tone and texture. | 2 | Liu H (2026) | Skin barrier repairing and anti-aging effects evaluation of a comprehensive topical regimen incorporating niacinamide, Pro-Xylane, and panthenol after PicoWay laser: a randomized controlled study. |
| Niacinamide Skin Randomized Trial | Pro-Xylane is a potent anti-aging ingredient; however, there is limited knowledge regarding whether a comprehensive post-procedure regimen incorporating a combination of Pro-Xylane, niacinamide, and panthenol alongside other active agents can deliver synergistic benefits for both skin barrier repair and anti-aging. | 2 | Liu H (2026) | Skin barrier repairing and anti-aging effects evaluation of a comprehensive topical regimen incorporating niacinamide, Pro-Xylane, and panthenol after PicoWay laser: a randomized controlled study. |
| Niacinamide Skin Randomized Trial | This study assesses the effectiveness of the REGENMEDIC cream (anti-aging cream) and REGENMEDIC serum (anti-aging serum) in promoting skin barrier recovery and enhancing anti-aging effects following PicoWay laser treatment. | 2 | Liu H (2026) | Skin barrier repairing and anti-aging effects evaluation of a comprehensive topical regimen incorporating niacinamide, Pro-Xylane, and panthenol after PicoWay laser: a randomized controlled study. |
| Niacinamide Skin Randomized Trial | The aim is to provide a mechanistically grounded and evidence‐oriented resource for researchers, dermatologists, and cosmetic scientists while distinguishing established clinical evidence from promising but still experimental approaches. | 3 | Chen Yuanyuan (2026) | Advances in Skin Whitening Agents: Mechanisms, Clinical Applications, and Future Perspectives |
| Niacinamide Skin Randomized Trial | A third type, neuromelanin, is found in specific brain regions but has limited relevance to skin pigmentation []. | 3 | Chen Yuanyuan (2026) | Advances in Skin Whitening Agents: Mechanisms, Clinical Applications, and Future Perspectives |
| Niacinamide Skin Randomized Trial | MITF Regulation by 32 33 34 35 36 37 Microphthalmia‐associated transcription factor (MITF) is a central regulator of melanocyte differentiation and melanogenic gene expression []. | 3 | Chen Yuanyuan (2026) | Advances in Skin Whitening Agents: Mechanisms, Clinical Applications, and Future Perspectives |
| Niacinamide Skin Randomized Trial | 1 2 Skin color is primarily determined by the amount, type, and distribution of melanin pigments in the epidermis. | 3 | Chen Yuanyuan (2026) | Advances in Skin Whitening Agents: Mechanisms, Clinical Applications, and Future Perspectives |
Source documents